Shares of The Macerich Company (NYSE:MAC – Get Free Report) have received a consensus rating of “Reduce” from the nine brokerages that are currently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $16.40.
MAC has been the subject of several research reports. The Goldman Sachs Group upped their price objective on shares of Macerich from $13.00 to $14.60 and gave the company a “sell” rating in a research note on Thursday, September 19th. Compass Point increased their price target on Macerich from $20.00 to $23.00 and gave the company a “buy” rating in a report on Thursday, November 7th. Piper Sandler upped their target price on Macerich from $11.00 to $14.00 and gave the company an “underweight” rating in a report on Tuesday, September 3rd. Bank of America lifted their price target on Macerich from $17.00 to $19.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Finally, StockNews.com lowered shares of Macerich from a “hold” rating to a “sell” rating in a report on Thursday, November 7th.
Check Out Our Latest Analysis on MAC
Macerich Price Performance
Macerich (NYSE:MAC – Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The real estate investment trust reported ($0.50) EPS for the quarter, missing the consensus estimate of $0.40 by ($0.90). Macerich had a net margin of 8.98% and a return on equity of 3.15%. The firm had revenue of $220.20 million during the quarter, compared to analyst estimates of $208.54 million. During the same period in the prior year, the company posted $0.44 earnings per share. The firm’s revenue for the quarter was up .9% compared to the same quarter last year. As a group, analysts predict that Macerich will post 1.58 EPS for the current fiscal year.
Macerich Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Tuesday, November 12th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Tuesday, November 12th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 3.21%. Macerich’s payout ratio is currently 174.36%.
Institutional Trading of Macerich
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Blue Trust Inc. raised its holdings in shares of Macerich by 152.2% in the 3rd quarter. Blue Trust Inc. now owns 1,546 shares of the real estate investment trust’s stock valued at $28,000 after buying an additional 933 shares during the period. Quest Partners LLC acquired a new position in Macerich in the 2nd quarter valued at about $50,000. GAMMA Investing LLC increased its stake in Macerich by 40.9% during the third quarter. GAMMA Investing LLC now owns 3,214 shares of the real estate investment trust’s stock worth $59,000 after purchasing an additional 933 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Macerich during the second quarter worth about $129,000. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Macerich by 34.8% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,374 shares of the real estate investment trust’s stock valued at $150,000 after purchasing an additional 2,161 shares during the period. Hedge funds and other institutional investors own 87.38% of the company’s stock.
Macerich Company Profile
Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich’s portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.
Read More
- Five stocks we like better than Macerich
- With Risk Tolerance, One Size Does Not Fit All
- Analog Devices: Why the Uptrend Could Accelerate in 2025
- Health Care Stocks Explained: Why You Might Want to Invest
- Texas Pacific Land: Permian Basin Powerhouse With an AI Edge
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- ServiceNow: Will the High-Flyer Finally Split in 2024?
Receive News & Ratings for Macerich Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Macerich and related companies with MarketBeat.com's FREE daily email newsletter.